Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Michael, Man"'
Autor:
Ernest Nadal, Mansoor Saleh, Santiago Ponce Aix, Maria Ochoa-de-Olza, Sandip Pravin Patel, Scott Antonia, Yumin Zhao, Ivelina Gueorguieva, Michael Man, Shawn T. Estrem, Jiangang Liu, Emin Avsar, Wen Hong Lin, Karim A. Benhadji, Leena Gandhi, Susan C. Guba, Inmaculada Ales Diaz
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background In this phase Ib/II open-label study, tumor immune suppression was targeted in patients with advanced refractory solid tumors and patients with recurrent/refractory non-small cell lung cancer (NSCLC) using galunisertib with nivolu
Externí odkaz:
https://doaj.org/article/f152b1db103e441ba5117026cc7aba88
Autor:
Chark, Robin, IP, Michael Man Him
Publikováno v:
In International Journal of Hospitality Management January 2023 108
Autor:
IP, Michael Man Him, Chark, Robin
Publikováno v:
In International Journal of Hospitality Management January 2023 108
Autor:
Antoine Hollebecque, Rocio Garcia-Carbonero, Do-Youn Oh, Emiliano Calvo, Davide Melisi, Teresa Macarulla, Valeria Merz, Erkut Borazanci, Anna Varghese, Camilla Zecchetto, Yumin Zhao, Ivelina Gueorguieva, Michael Man, Shawn T Estrem, Karim A Benhadji, Emin Avsar, Susan C Guba
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background We assessed the safety, efficacy, and pharmacokinetics of the transforming growth factor beta (TGFβ) receptor inhibitor galunisertib co-administered with the anti-programmed death-ligand 1 (PD-L1) antibody durvalumab in recurrent/refracto
Externí odkaz:
https://doaj.org/article/c175cf79b75445f3ae95a488c7252728
Autor:
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, Ed Gane, Valerie Paradis, Ann Cleverly, Claire Smith, Shawn T Estrem, Michael Man, Shuaicheng Wang, Michael M Lahn, Eric Raymond, Karim A Benhadji, Sandrine Faivre
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253671 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0222259.].
Externí odkaz:
https://doaj.org/article/2995cf4239874373a2d5d26500aa62c2
Autor:
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, Ed Gane, Valerie Paradis, Ann Cleverly, Claire Smith, Shawn T Estrem, Michael Man, Shuaicheng Wang, Michael M Lahn, Eric Raymond, Karim A Benhadji, Sandrine Faivre
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0222259 (2020)
BackgroundTransforming growth factor beta (TGF-β) signalling is involved in the development of hepatocellular carcinoma (HCC). We followed changes in biomarkers during treatment of patients with HCC with the TGF-βRI/ALK5 inhibitor galunisertib.Meth
Externí odkaz:
https://doaj.org/article/b94571adec37493990e021bf220fbe7b
Publikováno v:
Brazilian Journal of Cardiovascular Surgery, Iss 0 (2019)
Abstract Aortic valve disease is one of the most common valvular heart diseases in the cardiovascular category. Surgical replacement of the diseased aortic valve remains the definitive intervention for most diseases. There is a clear consensus that i
Externí odkaz:
https://doaj.org/article/27df3681c4a344faaec9f038fc331c1b
Autor:
M. Malek Bawadkji, Sai Deepika Potluri, Raj Dangol, Michael Man Kit Siu, Rabin K. Shrestha, Marcos A. Wolff, Christopher J. Haas
Publikováno v:
SN Comprehensive Clinical Medicine. 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe347aa9b1210249ea369a3ff9edcbe1
https://doi.org/10.1007/s42399-022-01169-2
https://doi.org/10.1007/s42399-022-01169-2
Autor:
Clayton D. Knox, Pieter‐Jan deKam, Karim Azer, Peggy Wong, Antwan G. Ederveen, Diane Shevell, Christopher Morabito, Alan G. Meehan, Wen Liu, Tom Reynders, Jean Francois Denef, Anna Mitselos, Daniel Jonathan, David E. Gutstein, Kaushik Mitra, Shu Yu Sun, Michael Man‐Chu Lo, Doris Cully, Amjad Ali
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 9, Pp n/a-n/a (2016)
Background Nitric oxide donors are widely used to treat cardiovascular disease, but their major limitation is the development of tolerance, a multifactorial process to which the in vivo release of nitric oxide is thought to contribute. Here we descri
Externí odkaz:
https://doaj.org/article/7cd174d677244bd59548edc692b1ac0a
Publikováno v:
The Journal of Organic Chemistry. 85:4807-4812
The therapeutic application of nitric oxide, an endogenous cellular signaling molecule, has been limited due to the difficulty of developing stable pro-drugs with slow kinetics of NO release. Diazeniumdiolates are valuable NO donors; however, synthet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f48e5529960a6e0702578b8db27d6e9f
https://doi.org/10.1021/acs.joc.0c00020
https://doi.org/10.1021/acs.joc.0c00020